Switching to integrase inhibitors from protease inhibitors is associated with new diabetes risk in people with HIV

Diabetes mellitus affects more than 10% of people with HIV, and its incidence is rising as the population ages, according to the National Institutes of Health. Antiretroviral therapies that treat HIV by blocking specific enzymes the virus uses to…

Continue Reading

News Source: medicalxpress.com